Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
about
Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatmentAnalysis of circulating microRNAs in adrenocortical tumorsAnalysis of flow cytometry data by matrix relevance learning vector quantizationPlasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronismComparison of metabolic ratios of urinary estrogens between benign and malignant thyroid tumors in postmenopausal women."Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study.Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure statusTranscutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome.Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.Evidence for Chronic Kidney Disease-Mineral and Bone Disorder Associated With Metabolic Pathway Changes.Adrenal cancer in neurofibromatosis type 1: case report and DNA analysisMolecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal TumorsAdrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades.Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseases.Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art.Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling.cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.Adrenocortical carcinoma: modern management and evolving treatment strategies.Current management options for recurrent adrenocortical carcinoma.Review of mass spectrometry-based metabolomics in cancer research.Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients.The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.17-Hydroxyprogesterone in children, adolescents and adults.Novel methodologies in analysis of small molecule biomarkers and living cells.Application of chemometric techniques in search of clinically applicable biomarkers of disease.Diagnosis, treatment and outcome of adrenocortical cancer.Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer.Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).Derivatization of steroids in biological samples for GC-MS and LC-MS analyses.5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications.5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.Prototype-based models in machine learning.Genetics of adrenocortical tumours.Proteome analysis of adrenal cortical tumors.Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.Metabolomics for the masses: The future of metabolomics in a personalized world.Gas chromatography tandem mass spectrometry offers advantages for urinary steroids analysis.
P2860
Q26801839-F56C9AF8-41E3-4DDA-A152-7D4622CFAD59Q28303947-CD1098AB-4FAB-42A5-8D19-4CF3AA0EC45CQ30606810-880FEA83-648B-4525-A6EC-06DEE5FC2351Q33458909-621D0FD8-FCC6-42B7-A8D7-DE1B716BF03DQ33579003-062A81F9-6E71-4752-B469-4E542EB60A0BQ33592326-DE2AA35F-5A04-4B0D-94AB-D6D0024CD922Q33752160-23AEFF9F-009E-4C04-9AE9-54841113DD87Q33890991-4820D01E-734D-46A1-A576-8C4749FB29D6Q33896706-F37CCB9A-503E-4533-8F50-54378517F284Q33905628-3E11199D-39DD-41AE-826A-369052241777Q34489191-0A418245-7E76-4613-B181-7667E293F3FDQ34561573-472CD2BC-342E-497F-8DA0-20F725DE2AA9Q34810821-A18A796E-92BD-4FD3-88A3-1DA18FCA5C49Q35801476-F184C443-55A8-4FA6-8C0F-66F4A4491386Q35960108-94661C49-9F1C-4588-A763-055471FEE489Q36222080-EE1B0F15-BE9D-4FD2-9162-3DB6B54E7F5CQ36355661-F3ED4E5B-1034-4EE9-973F-A527F6411046Q36540950-11A88C04-3253-46F0-B090-6C562A0F8D1AQ36763148-8F799682-E499-4C07-99EB-DC77ABA27962Q36908711-9C414C9C-9CC7-4838-869B-F52957AE1DA9Q36925876-631B80B1-FC8D-4864-BE0F-F75CB8314E8DQ37550758-85484D7E-1FB0-434D-8CAF-F61F80F6C8C8Q37690743-53FC3300-6BC6-4E44-B776-5B6F3DACAA7FQ38089640-5C56A1C7-880F-48B5-9A1A-F04D8C55458DQ38202944-BF650B58-C9FC-4FB4-B8A3-60B481719B75Q38239586-FF6E374F-512F-4BEB-924E-3295E3830774Q38243626-3CD87B2B-EA16-45A4-A931-DD7F01D337D5Q38358503-871E7E64-EAE0-4E19-A491-9D5821D4AE17Q38506337-0D509998-C47D-4AC9-9849-4D40583E0AF7Q38545507-5B83D5E4-08CF-48CD-A954-C67D79355465Q38610529-C28EE9D3-DD50-4951-B584-2A8D20593E78Q38667419-06B5E742-5167-4833-8DFC-D33DCDAAEC35Q38668953-944158EF-24EA-45E6-90D2-9921BFB59F08Q38708126-EF79CC6D-3B18-4C89-AFAD-EE1E9A07538FQ38793396-99A8A16D-FF39-48EB-BDA1-391C86103E02Q38888303-AB0B08A8-A5C3-4D2B-96BF-832AF699D862Q39088498-F4054CA5-9109-457D-95C1-C05E47E0D2FEQ44833200-FB64A798-FB9C-4990-B5AA-7F9435251ACBQ44951888-0D06245A-B232-4F7B-8A15-5CA4AB5F073CQ47137865-ED6C00E4-36B6-4F73-B877-B3C7F00D7CAF
P2860
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@ast
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@en
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@en-gb
type
label
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@ast
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@en
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@en-gb
prefLabel
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@ast
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@en
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@en-gb
P2093
P2860
P50
P356
P1476
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
@en
P2093
Beverly A Hughes
Bruno Allolio
Cedric H L Shackleton
Emilio Porfiri
Franco Mantero
Han Stiekema
Martin Fassnacht
Paul M Stewart
Peter Nightingale
Petra Schneider
P2860
P304
P356
10.1210/JC.2011-1565
P407
P50
P577
2011-09-14T00:00:00Z